
Breakthrough combination therapy tackles drug resistance in lung cancer with common KRAS mutation
RICHMOND, Va. — A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have uncovered a powerful combination therapy leveraging sotorasib—an FDA-approved drug in the market—and an experimental …